Cynic
Graduate Poster
- Joined
- Aug 26, 2009
- Messages
- 1,329
If it seems absurd that someone would merely be pointing out that the sky is blue, then why should our first instinct be to assume that's what he's saying? Sometimes it seems as if people go out of their way to misunderstand others. I don't know Rodney, but it seems a more charitable interpretation would be that he feels not enough effort is being put into assessing and communicating those risks at multiple levels. From there, the conversation could go any number of directions, but it hasn't gone in most of them.
The practicable application of quality control and assurance (as applies to UncaYimmy's peanut butter example) is a different thing altogether. No one is saying that drugs aren't made per spec. As I see it, the problem is systemic and mostly human. It wasn't too long ago that physician practices were forbidden to accept gifts and advertising paraphernalia (pads, pens, etc) from pharmaceutical companies for precisely these reasons. The more compensation of any sort doctors got related to a particular medication, the more likely they were to prescribe it. Tendencies like that can only mean that appropriateness, risk assessment, and informed decisions aren't the only factors involved -- but they should be. Drugs aren't just prescribed, they are marketed. Even under the best of conditions, doctors are only able to perform their duty as well as the information they're able -- or willing -- to access. The FDA itself, whose role it is to protect people, receives much of its funding based on the success of the very products it oversees. Not much of an incentive to shut some of the blockbuster drugs down, or smite the their manufacturers for withholding critical negative information.
That's what color the sky is, but it doesn't have to be that color forever. More can be done to ensure that patients and doctors are aware of both the potential risks and benefits of the medications and treatments they're prescribed. I'm not calling the industry bad here -- I'm saying there's opportunity for improvement.
The practicable application of quality control and assurance (as applies to UncaYimmy's peanut butter example) is a different thing altogether. No one is saying that drugs aren't made per spec. As I see it, the problem is systemic and mostly human. It wasn't too long ago that physician practices were forbidden to accept gifts and advertising paraphernalia (pads, pens, etc) from pharmaceutical companies for precisely these reasons. The more compensation of any sort doctors got related to a particular medication, the more likely they were to prescribe it. Tendencies like that can only mean that appropriateness, risk assessment, and informed decisions aren't the only factors involved -- but they should be. Drugs aren't just prescribed, they are marketed. Even under the best of conditions, doctors are only able to perform their duty as well as the information they're able -- or willing -- to access. The FDA itself, whose role it is to protect people, receives much of its funding based on the success of the very products it oversees. Not much of an incentive to shut some of the blockbuster drugs down, or smite the their manufacturers for withholding critical negative information.
That's what color the sky is, but it doesn't have to be that color forever. More can be done to ensure that patients and doctors are aware of both the potential risks and benefits of the medications and treatments they're prescribed. I'm not calling the industry bad here -- I'm saying there's opportunity for improvement.
.it was marketed as a go out and dance again drug just as Celebrex is.